<DOC>
	<DOCNO>NCT01349270</DOCNO>
	<brief_summary>Treatment Chronic Inflammatory Demyelinating Polyneuropathy ( CIDP ) challenge disease may generate important disability patient include young adult . Randomized trial show corticosteroid , plasma exchange intravenous immunoglobulin ( IVIg ) reduce impairment short term period treatment chronic disease n't agree . Corticosteroids IVIg first line CIDP treatment . No study permit demonstrate superiority one treatment . Long term adverse effect corticosteroid IVIg cost respective limitation use . The investigator schedule recruit 40 CIDP patient 23 French centre receive either 0,8mg/kg/day prednisone progressively taper 6 month monthly 2g/kg cure IVIg 6 month . Patients follow 6 month treatment .</brief_summary>
	<brief_title>Randomized Open-label Trial Compare Efficacy Tolerance Corticosteroids IVIg</brief_title>
	<detailed_description />
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Polyradiculoneuropathy , Chronic Inflammatory Demyelinating</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Man woman 18 80 , Weight ≤ 100 kg , CIDP diagnosis : stable deteriorated state ( spontaneous improvement ) , follow feature : motor sensory motor deficit , reduce abolish tendon reflex , progressive relapsing evolution , global symmetric disability one limb , disease course installation least 2 month , cerebrospinal fluid ≤10/µL white blood cell &gt; 0.5 g/L protein rate ( non compulsory examination ) , electrophysiological histological sign demyelinization , INCAT disability score ≥ 2 arm ≥ 1 leg Severe electrophysiological axonal damage , Pure motor syndrome , Spontaneous improvement , Associated systemic disease could cause neuropathy , Severe cardiac insufficiency , Cardiac arrhythmia , Severe cardiopulmonary pathology , Inflammatory syndrome , Severe physical disease interfere trial , Patient strict saltfree diet , A clinically significant abnormal biological result , Positive serology one follow test : HIV1 , HIV2 , ABC hepatitis , Hbs antigen , Lyme disease , IgA complete deficiency , History anaphylactic reaction previous IVIg infusion , Hypogammaglobulinemia ( IgG &lt; 3g/L ) , Creatinine clearance &lt; 80 mL/min , Evolutive gastroduodenal ulcer , diabetes , serious infectious condition , evolutive virus disease ( hepatite , herpes , varicella , zona ) , psychotic state control treatment , veinous arterial thrombosis , non control high blood pressure , osteoporosis , Patient previously treat corticosteroid , IVIg , plasma exchange immunosuppressive agent within 3 month inclusion , except azathioprine mycophenolate mofetil tolerate case dose unmodified within 3 month keep unchanged trial , Experienced failure IVIG prednisone prior treatment , Hypersensitivity components 2 treatment , Unsigned informed consent , Ongoing plan pregnancy ( mandatory pregnancy test screen visit ) , breastfeed , effective contraception 3 month woman childbearing age .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>chronic inflammatory demyelinate polyneuropathy</keyword>
	<keyword>immunoglobulin</keyword>
	<keyword>prednisone</keyword>
</DOC>